Down-regulation of the neurotrophin receptor TrkB following ligand binding - Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB

被引:140
作者
Sommerfeld, MT [1 ]
Schweigreiter, R [1 ]
Barde, YA [1 ]
Hoppe, E [1 ]
机构
[1] Max Planck Inst Neurobiol, Dept Neurobiochem, D-82152 Planegg Martinsried, Germany
关键词
D O I
10.1074/jbc.275.12.8982
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study examines the mechanisms by which the tyrosine kinase receptor TrkB is down-regulated following binding of brain-derived neurotrophic factor (BDNF). In primary cultures of cerebellar granule neurons, BDNF-induced reduction of TrkB receptors was largely prevented by the addition of specific proteasome inhibitors. HN10 cells, a neuronal cell line that can be readily transfected, also showed a marked down-regulation of cell surface TrkB following BDNF exposure. In addition, me observed that prolonged exposure to nerve growth factor of TrkA-transfected cells did not lead to the down-regulation seen with BDNF and TrkB. TrkA and TrkB chimeric molecules were therefore expressed in HN10 cells and tested for ligand-induced regulation. These experiments led to the conclusion that the motives responsible for down-regulation are contained in the cytoplasmic domain of TrkB, and a short sequence in the juxtamembrane domain of TrkB was identified that confers nerve growth factor-induced down-regulation when inserted into TrkA.
引用
收藏
页码:8982 / 8990
页数:9
相关论文
共 45 条
[21]   THE TRKB TYROSINE PROTEIN-KINASE GENE CODES FOR A 2ND NEUROGENIC RECEPTOR THAT LACKS THE CATALYTIC KINASE DOMAIN [J].
KLEIN, R ;
CONWAY, D ;
PARADA, LF ;
BARBACID, M .
CELL, 1990, 61 (04) :647-656
[22]   Ligand-induced down-regulation of Trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons [J].
Knusel, B ;
Gao, H ;
Okazaki, T ;
Yoshida, T ;
Mori, N ;
Hefti, F ;
Kaplan, DR .
NEUROSCIENCE, 1997, 78 (03) :851-862
[23]  
LEE HJ, 1990, J NEUROSCI, V10, P1779
[24]   c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor [J].
Levkowitz, G ;
Waterman, H ;
Zamir, E ;
Kam, Z ;
Oved, S ;
Langdon, WY ;
Beguinot, L ;
Geiger, B ;
Yarden, Y .
GENES & DEVELOPMENT, 1998, 12 (23) :3663-3674
[25]   Heregulin β1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein [J].
Magnifico, A ;
Tagliabue, E ;
Ardini, E ;
Casalini, P ;
Colnaghi, MI ;
Ménard, S .
FEBS LETTERS, 1998, 422 (02) :129-131
[26]   RECOMBINANT EXPRESSION AND PROPERTIES OF THE KUNITZ-TYPE PROTEASE-INHIBITOR MODULE FROM HUMAN TYPE-VI COLLAGEN ALPHA-3(VI) CHAIN [J].
MAYER, U ;
POSCHL, E ;
NISCHT, R ;
SPECKS, U ;
PAN, TC ;
CHU, ML ;
TIMPL, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 225 (02) :573-580
[27]   Polyubiquitination and proteasomal degradation of the p185(c-erbB-2) receptor protein-tyrosine kinase induced by geldanamycin [J].
Mimnaugh, EG ;
Chavany, C ;
Neckers, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22796-22801
[28]  
MIYAZAWA K, 1994, BLOOD, V83, P137
[29]  
MORI S, 1992, J BIOL CHEM, V267, P6429
[30]   DEGRADATION PROCESS OF LIGAND-STIMULATED PLATELET-DERIVED GROWTH-FACTOR BETA-RECEPTOR INVOLVES UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY [J].
MORI, S ;
TANAKA, K ;
OMURA, S ;
SAITO, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (49) :29447-29452